Telix Strengthens Board with Additional Director Appointments

Stock Information for Anika Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports Fourth Quarter and Full Year 2025 Financial Results
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.
Anika Therapeutics Announces Leadership Transition
ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.